Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global ...
Anthropic has opened applications for a new round of its AI for Science programme focused on rare genetic diseases, offering ...
Finding new drugs, and finding new uses for existing drugs, remains slow, expensive, and associated with a high failure rate. Research now has access to ...
Artificial Intelligence (AI) is rapidly transforming pharmaceutical innovation by replacing traditional “wet” laboratory operations with ...
A new wave of artificial intelligence (AI) tools is emerging to help speed scientific discovery, especially in biomedical ...
America is having the wrong argument about AI data centers. One side sees windowless industrial giants devouring electricity and water while shifting the infrastructure bill onto families who are ...
Artificial intelligence is moving from the margins of virology into its operational core. It can scan viral genomes, ...
Atropos Health, the world’s largest creator of real-world evidence (RWE) for clinical decision making, today announced that it has contributed to 12 new studies in the first six months of 2026, ...
Discover how Dr. Ohmini Krishnamurthy Rajendran, an Indian physician-scientist, is revolutionizing precision oncology. Her ...
Moxham currently leads Transcripta Bio as founder and CEO. The AI-driven drug discovery start-up is developing small molecule ...
Spread the love“`html The pharmaceutical industry, traditionally a marathon of painstaking research and development, is in ...
The advent of agentic AI (artificial intelligence)-for-science tools has challenged the long-held assumption that creative hypothesis generation is an innately human capability. Indeed, beyond ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results